Replies to post #240362 on Biotech Values

[vinmantoo]

I thought someone might comment on JNJ/ARWR’s HBV data presented yesterday. For what’s it’s worth, I thought it was basically meh.

It made more excited about ENTA's EDP-514 data for HepB.

[willyw]

Not as good as Enanta's HBV data - but better than Roche's/AVIR's Covid data.